Baird Financial Group, Inc. Enanta Pharmaceuticals Inc Transaction History

Baird Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $157,518 - $195,599	3,397 New	3,397 $210,000
Q1 2020 May 14, 2020	SELL	$40.22 - $62.0 $176,445 - $271,994	-4,387 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $1.78 Million - $2.04 Million	-30,684 Reduced 87.49%	4,387 $271,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $46,922 - $68,860	781 Added 2.28%	35,071 $2.11 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $2.79 Million - $3.34 Million	34,290 New	34,290 $2.89 Million

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $147M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.